ANI Pharmaceuticals Director Renee Tannenbaum Receives Restricted Stock Award

This Form 4 filing reports that Renee P. Tannenbaum, a director of ANI Pharmaceuticals Inc., received a restricted stock award of 4,357 shares of common stock on May 21, 2026. The shares were awarded at $0.00 per share and represent a restricted stock award that will fully vest on May 21, 2027. Following this transaction, Tannenbaum's total direct holdings in ANI Pharmaceuticals increased to 29,514 shares. The filing was signed on June 10, 2026, by attorney-in-fact Meredith W. Cook on behalf of Tannenbaum. This transaction represents a standard equity compensation award to a non-employee director, which is common practice for aligning director interests with shareholder value creation.